FiercePharma4h
Gearing up to challenge Lilly in obesity, Kailera picks Zepbound brand leader as new commercial chief
The biotech has named Jamie Coleman its chief commercial officer, per a Monday announcement, putting her in charge of the ...
JD Supra5h
The GLP-1 Saga Continues: FDA Ends the Tirzepatide Shortage: Frequently Asked Questions
FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly ...
pharmaphorum19h
FDA rethinking block on compounding of Lilly's obesity drug
The FDA has said it has agreed to reconsider its decision to prevent compounding pharmacies from producing and selling versions of Eli ... sold by Lilly as Mounjaro for diabetes and Zepbound ...
thedailyupside17h
Novo Nordisk May Have Another Blockbuster on its Hands
On Friday, the Danish pharma giant released the stellar results from a phase 1/2 trial for a once-weekly jab in its pipeline.
Greek Reporter19h
Greek News
The Jews of Zakynthos, Greece's beautiful Ionian island, owe their survival during the dark days of the German occupation to two brave Greeks. Zakynthos, also known as Zante, is famous worldwide for ...